AI-Powered breathing monitor could spot lung trouble early
NCT ID NCT07164586
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests a new, non-invasive device called the Respiratory Diagnostic Assistant that uses artificial intelligence to monitor breathing patterns. Researchers will enroll 300 adults in emergency care who are at risk of acute respiratory failure. The goal is to see if the device accurately measures breathing and is easy to use, which could help doctors make faster, more objective decisions.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Respiratory Diagnostic Assistant (a non-invasive breathing monitor)
- What this could lead to
- If successful, this device could help doctors quickly and accurately spot breathing problems, potentially leading to earlier treatment for respiratory failure.
- What could go wrong
- This is an early-stage study focused on accuracy and usability, not on treatment outcomes. The device may not prove reliable enough for widespread use, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 300 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2025
- Expected to finish
-
Dec 2025
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The population will be composed of healthy participants and patients awaiting care or receiving emergency care in hospital emergency departments and emergency care units affiliated with the study, who are in spontaneous breathing, with or without oxygen therapy, at risk of acute respiratory failure.
- Ages
-
18 to 90 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Volunteers and patients of both sexes * Age greater than or equal to 18 years * Spontaneous breathing * Patients awaiting care in emergency departments, urgent care units, and emergency services * Presence of complaints associated with respiratory difficulty * Patients at risk of acute respiratory failure * With or without supplemental oxygen therapy * Ability to remain without oxygen therapy for a minimum period of three minutes Exclusion Criteria: * Psychomotor agitation * Anxiety validated through qualitative assessment * Poor mask fit and/or presence of air leaks * Facial fracture or trauma * Refusal to participate in the study or sign the informed consent form * Contraindications to performing manovacuometry and spirometry, when appropriate, according to the recommendations of the American Thoracic Society and European Respiratory Society (Graham et al., 2019)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Patients at risk of acute respiratory failure are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Physical Therapy
Recife, Pernambuco, 50740-560, Brazil
-
Emergency Care Unit from Engenho Velho
Jaboatão dos Guararapes, Pernambuco, 54160-000, Brazil
-
Otávio de Freitas Hospital
Recife, Pernambuco, 50920-640, Brazil